secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K/A
Filed at:   2026-09-28T21:06:57+00:00
Accession:  0001104659-26-111408
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Accendra Health names Kenneth Gardner-Smith CEO on October 5, 2026; Pesicka to advise up to 30 months
--------------------------------------------------------------------------------

- Kenneth Gardner-Smith was named President and CEO, with a mutually agreed start date of October 5, 2026; Edward A. Pesicka remains CEO until then.
- Pesicka will retire from the Board on October 5, 2026 and entered a September 28, 2026 consulting agreement to serve as an advisor for up to thirty months.
- The consulting term ends on the earlier of March 31, 2029, Pesicka's death or disability, or an uncured material breach 30 days after notice.
- Pesicka's outstanding equity awards remain outstanding and continue to vest during the consulting term; he will receive the COBRA Benefit for up to 18 months.
- The agreement includes a release of claims and keeps non-competition, non-solicitation, and confidentiality covenants from his March 9, 2026 Leadership Teammate Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000110465926111408/0001104659-26-111408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000110465926111408/ach-20260916x8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-111408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer